Header Logo

Connection

Lawrence Kushi to Retrospective Studies

This is a "connection" page, showing publications Lawrence Kushi has written about Retrospective Studies.
Connection Strength

0.506
  1. Obesity and related conditions and risk of inflammatory breast cancer: a nested case-control study. Breast Cancer Res Treat. 2020 Sep; 183(2):467-478.
    View in: PubMed
    Score: 0.108
  2. Preliminary Development and Evaluation of an Algorithm to Identify Breast Cancer Chemotherapy Toxicities Using Electronic Medical Records and Administrative Data. J Oncol Pract. 2015 01; 11(1):e1-8.
    View in: PubMed
    Score: 0.071
  3. Pubertal Timing Across Asian American, Native Hawaiian, and Pacific Islander Subgroups. JAMA Netw Open. 2024 May 01; 7(5):e2410253.
    View in: PubMed
    Score: 0.035
  4. Comparison of Mammography AI Algorithms with a Clinical Risk Model for 5-year Breast Cancer Risk Prediction: An Observational Study. Radiology. 2023 06; 307(5):e222733.
    View in: PubMed
    Score: 0.033
  5. Quantifying cancer risk from exposures to medical imaging in the Risk of Pediatric and Adolescent Cancer Associated with Medical Imaging (RIC) Study: research methods and cohort profile. Cancer Causes Control. 2022 May; 33(5):711-726.
    View in: PubMed
    Score: 0.030
  6. Recall of diet during a past pregnancy. Am J Epidemiol. 2001 Dec 15; 154(12):1136-42.
    View in: PubMed
    Score: 0.030
  7. Adjuvant endocrine therapy for breast cancer patients: impact of a health system outreach program to improve adherence. Breast Cancer Res Treat. 2020 Feb; 180(1):219-226.
    View in: PubMed
    Score: 0.026
  8. Trends in Medical Imaging During Pregnancy in the United States and Ontario, Canada, 1996 to 2016. JAMA Netw Open. 2019 07 03; 2(7):e197249.
    View in: PubMed
    Score: 0.025
  9. Primary care visit use after positive fecal immunochemical test for colorectal cancer screening. Cancer. 2017 Oct 01; 123(19):3744-3753.
    View in: PubMed
    Score: 0.022
  10. Body mass index, PAM50 subtype, recurrence, and survival among patients with nonmetastatic breast cancer. Cancer. 2017 Jul 01; 123(13):2535-2542.
    View in: PubMed
    Score: 0.021
  11. Effect of Angiotensin System Inhibitors on Survival in Patients Receiving Chemotherapy for Advanced Non-Small-Cell Lung Cancer. Clin Lung Cancer. 2017 03; 18(2):189-197.e3.
    View in: PubMed
    Score: 0.020
  12. Breast cancer multigene testing trends and impact on chemotherapy use. Am J Manag Care. 2016 05 01; 22(5):e153-60.
    View in: PubMed
    Score: 0.020
  13. Use of Bevacizumab in Community Settings: Toxicity Profile and Risk of Hospitalization in Patients With Advanced Non-Small-Cell Lung Cancer. J Oncol Pract. 2015 Sep; 11(5):356-62.
    View in: PubMed
    Score: 0.019
  14. KRAS testing and epidermal growth factor receptor inhibitor treatment for colorectal cancer in community settings. Cancer Epidemiol Biomarkers Prev. 2013 Jan; 22(1):91-101.
    View in: PubMed
    Score: 0.016
  15. Patterns and predictors of first-line chemotherapy use among adults with advanced non-small cell lung cancer in the cancer research network. Lung Cancer. 2012 Dec; 78(3):245-52.
    View in: PubMed
    Score: 0.016
  16. Lung cancer survival with herbal medicine and vitamins in a whole-systems approach: ten-year follow-up data analyzed with marginal structural models and propensity score methods. Integr Cancer Ther. 2011 Sep; 10(3):260-79.
    View in: PubMed
    Score: 0.014

© 2025 Kaiser Permanente